Omeros Corp SEC filings OMER

Omeros Corp has 810 filings in SEC EDGAR's recent list, going back to Mar 31, 2004. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.

Omeros Corp SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 30, 2026 Oct 28, 2026
S-8 Employee stock plan registration Aug 13, 2026 —
8-K Current report
Officer or director change
Aug 13, 2026 Aug 12, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Other events
Jul 20, 2026 Jul 20, 2026
8-K Current report
Other events
Jul 6, 2026 Jul 2, 2026
8-K Current report
Shareholder vote results
Jun 25, 2026 Jun 18, 2026
8-K Current report
Other events
Jun 18, 2026 Jun 17, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Jun 18, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
8-K Current report
Results of operations
Jan 7, 2026 Jan 7, 2026
8-K Current report
Other events
Dec 29, 2025 Dec 24, 2025
8-K Current report
Agreement ended, Acquisition or sale of assets, Other events
Dec 1, 2025 Nov 25, 2025
424B5 Prospectus supplement Nov 14, 2025 —
S-3ASR Automatic shelf registration Nov 14, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K Current report
Material agreement, Other events
Oct 15, 2025 Oct 10, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Other events
Jul 25, 2025 Jul 24, 2025
424B5 Prospectus supplement Jul 25, 2025 —
8-K Current report
Shareholder vote results
Jul 2, 2025 Jun 27, 2025
ARS Annual report to shareholders May 30, 2025 Dec 31, 2024
DEF 14A Proxy statement May 30, 2025 Jun 27, 2025
8-K/A Amended current report May 16, 2025 May 12, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Other events
May 15, 2025 May 12, 2025
8-K Current report
Other events
May 6, 2025 May 6, 2025
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K Current report
Other events
Feb 20, 2025 Feb 20, 2025
8-K Current report
Other events
Jan 16, 2025 Jan 16, 2025
8-K Current report
Other events
Dec 19, 2024 Dec 19, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 12, 2024 Jun 6, 2024
8-K Current report
Material agreement, New debt, Regulation FD disclosure, Other events
Jun 3, 2024 Jun 3, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
DEF 14A Proxy statement Apr 29, 2024 Jun 6, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 1, 2024 Apr 1, 2024
8-K Current report
Material agreement, New debt
Feb 7, 2024 Feb 1, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Other events
Oct 16, 2023 Oct 16, 2023
S-8 Employee stock plan registration Aug 9, 2023 —
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 28, 2023 Jun 23, 2023
ARS Annual report to shareholders May 17, 2023 Dec 31, 2022
DEF 14A Proxy statement May 17, 2023 Jun 23, 2023
8-K Current report
Officer or director change
May 16, 2023 May 12, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
10-K Annual report Mar 13, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 13, 2023 Mar 13, 2023
8-K Current report
Results of operations, Other events
Feb 6, 2023 Feb 6, 2023
424B5 Prospectus supplement Nov 18, 2022 —
424B3 Prospectus Nov 18, 2022 —
EFFECT Filing Nov 17, 2022 —
CORRESP Letter to the SEC Nov 16, 2022 —
UPLOAD Letter from the SEC Nov 15, 2022 —
S-3 Shelf registration Nov 9, 2022 —
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
8-K Current report
Material agreement, New debt
Oct 6, 2022 Sep 30, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Shareholder vote results
Jun 24, 2022 Jun 17, 2022
EFFECT Filing May 10, 2022 —
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
DEF 14A Proxy statement May 2, 2022 Jun 17, 2022
POS AM Filing Mar 1, 2022 —
10-K Annual report Mar 1, 2022 Dec 31, 2021
POSASR Filing Mar 1, 2022 —
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
8-K Current report
Acquisition or sale of assets, Other events
Dec 30, 2021 Dec 23, 2021
8-K Current report
Material agreement, Other events
Dec 2, 2021 Dec 1, 2021
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Oct 18, 2021 Oct 14, 2021
8-K Current report
Other events
Oct 1, 2021 Oct 1, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
S-8 Employee stock plan registration Jun 16, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 16, 2021 Jun 11, 2021
8-K Current report
Other events
May 20, 2021 May 20, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
DEF 14A Proxy statement Apr 30, 2021 Jun 11, 2021
424B5 Prospectus supplement Mar 1, 2021 —
10-K Annual report Mar 1, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 1, 2021 Mar 1, 2021
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
8-K Current report
Material agreement, Other events
Aug 14, 2020 Aug 11, 2020
424B5 Prospectus supplement Aug 13, 2020 —
424B5 Prospectus supplement Aug 13, 2020 —
FWP Free writing prospectus Aug 12, 2020 —
424B5 Prospectus supplement Aug 10, 2020 —
424B5 Prospectus supplement Aug 10, 2020 —
305B2 Filing Aug 10, 2020 —
FWP Free writing prospectus Aug 10, 2020 —
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
CT ORDER Filing Aug 6, 2020 —
8-K Current report
Shareholder vote results
Jun 11, 2020 Jun 5, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 5, 2020
10-K Annual report Mar 2, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 2, 2020 Mar 2, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 11, 2020 Feb 5, 2020
UPLOAD Letter from the SEC Jan 31, 2020 —
AW Filing Jan 13, 2020 —
CORRESP Letter to the SEC Jan 10, 2020 —
UPLOAD Letter from the SEC Dec 30, 2019 —
8-K Current report
Material agreement, Other events
Dec 6, 2019 Dec 5, 2019
424B5 Prospectus supplement Dec 6, 2019 —
424B5 Prospectus supplement Dec 4, 2019 —
S-3ASR Automatic shelf registration Dec 4, 2019 —
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
CT ORDER Filing Sep 11, 2019 —
10-Q Quarterly report Aug 8, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Material agreement, New debt
Aug 8, 2019 Aug 2, 2019
8-K Current report
Material agreement
Jul 31, 2019 Jul 28, 2019
S-8 Employee stock plan registration Jun 11, 2019 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2019 Jun 7, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
DEF 14A Proxy statement Apr 29, 2019 Jun 7, 2019
CT ORDER Filing Apr 4, 2019 —
POS AM Filing Mar 1, 2019 —
10-K Annual report Mar 1, 2019 Dec 31, 2018
POSASR Post-effective amendment no.1 to form s-3 Mar 1, 2019 —
8-K Current report
Results of operations
Mar 1, 2019 Mar 1, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 12, 2019 Feb 9, 2019
8-K Current report
Results of operations
Jan 14, 2019 Jan 14, 2019
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
Nov 15, 2018 Nov 8, 2018
10-Q Quarterly report Nov 8, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 8, 2018 Nov 8, 2018
8-K Current report
Other events
Oct 5, 2018 Oct 4, 2018
CT ORDER Filing Oct 4, 2018 —
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 9, 2018 Aug 9, 2018
8-K Current report
Shareholder vote results
Jun 18, 2018 Jun 15, 2018
8-K Current report
Material agreement, Other events
May 24, 2018 May 22, 2018
8-K Current report
Other events
May 21, 2018 May 18, 2018
8-K Current report
Results of operations
May 10, 2018 May 10, 2018
10-Q Quarterly report May 10, 2018 Mar 31, 2018
DEF 14A Proxy statement Apr 30, 2018 Jun 15, 2018
8-K Current report
Material agreement
Apr 13, 2018 Apr 10, 2018
8-K Current report
Other events
Mar 27, 2018 Mar 23, 2018
10-K Annual report Mar 1, 2018 Dec 31, 2017
8-K Current report
Results of operations
Mar 1, 2018 Mar 1, 2018
10-Q Quarterly report Nov 9, 2017 Sep 30, 2017
8-K Current report
Results of operations
Nov 9, 2017 Nov 9, 2017
8-K Current report
Material agreement
Oct 17, 2017 Oct 11, 2017
8-K Current report
Material agreement, Other events
Oct 5, 2017 Oct 4, 2017
8-K Current report
Other events
Aug 23, 2017 Aug 23, 2017
8-K Current report
Material agreement, Other events
Aug 17, 2017 Aug 14, 2017
424B5 Prospectus supplement Aug 16, 2017 —
424B5 Prospectus supplement Aug 14, 2017 —
S-3ASR Automatic shelf registration Aug 14, 2017 —
8-K Current report
Other events
Aug 14, 2017 Aug 14, 2017
10-Q Quarterly report Aug 8, 2017 Jun 30, 2017
8-K Current report
Results of operations
Aug 8, 2017 Aug 8, 2017
CT ORDER Filing Jun 26, 2017 —
8-K Current report
Shareholder vote results, Other events
Jun 22, 2017 Jun 16, 2017
S-8 Employee stock plan registration Jun 21, 2017 —
10-Q Quarterly report May 10, 2017 Mar 31, 2017
8-K Current report
Results of operations
May 10, 2017 May 10, 2017
CT ORDER Filing May 10, 2017 —
DEF 14A Proxy statement Apr 25, 2017 Jun 16, 2017
S-8 Employee stock plan registration Mar 16, 2017 —
10-K Annual report Mar 16, 2017 Dec 31, 2016
8-K Current report
Results of operations
Mar 16, 2017 Mar 16, 2017
NO ACT Auto-generated paper document Jan 25, 2017 Jan 10, 2017
CT ORDER Filing Dec 21, 2016 —
8-K Current report
Results of operations
Nov 9, 2016 Nov 9, 2016
10-Q Quarterly report Nov 9, 2016 Sep 30, 2016
CT ORDER Filing Oct 27, 2016 —
8-K Current report
Material agreement, Agreement ended, New debt
Oct 27, 2016 Oct 26, 2016
8-K Current report
Material agreement, Other events
Aug 15, 2016 Aug 11, 2016

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OMER (Nasdaq)
Fiscal year ends
December 31
Incorporated in
WA
Headquarters
Seattle, WA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1285819

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.